Skip to main content
. Author manuscript; available in PMC: 2014 Sep 15.
Published in final edited form as: Cochrane Database Syst Rev. 2012 Feb 15;2:CD009665. doi: 10.1002/14651858.CD009665

Analysis 1.1. Comparison 1 Subcutaneous sumatriptan 4 mg versus placebo, Outcome 1 Pain-free at 2 h.

Review: Sumatriptan (subcutaneous route of administration) for acute migraine attacks in adults

Comparison: 1 Subcutaneous sumatriptan 4 mg versus placebo

Outcome: 1 Pain-free at 2 h

graphic file with name emss-58494-t0009.jpg